Evommune Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Related People
Fund Service Providers
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Evommune Inc
TickerEVMN
CIK #0002044725
CUSIP30054Y107
SectorLife Sciences - Pharmaceutical Preparations
Address1841 Page Mill Rd, Palo Alto, CA 94304
Source [EDGAR]
CIK Filing 2011 - 2026
[0002044725] 10-K
[0002044725] 10-Q
[0002044725] 3
[0002044725] 4
[0002044725] 8-K
[0002044725] D
[0002044725] SC 13D
[0002044725] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Point72 Asset Management LP Evommune Inc [2026-07-16] 0.0
Pivotal Bioventure Partners Fund I LP Evommune Inc [2026-02-13] 0.0
Andera Partners Evommune Inc [2025-11-17] 0.0
RA Capital Management LP Evommune Inc [2025-11-17] 0.0
LSP 7 Cooperative UA Evommune Inc [2025-11-14] 0.0
Form 3/4/5 Filer 2011 - 2026
Kirsch Arthur S
Evommune, Inc.
Pena Luis C.
Patel Jeegar Pravinkumar
Drew Janice Suzann
McGraw Benjamin F III
Cohen David E
Carver Kyle
Moss Gregory S.
Bauer Eugene
LSP 7 Cooperative UA
Verduyn-van Weegen Felice Isabel
Shah Rajeev M.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund III, L.P.
RA Capital Management LP
Kolchinsky Peter
Hopfner Robert Lorne
Pivotal bioVenture Partners Fund I U.G.P. Ltd
Pivotal bioVenture Partners Fund I, L.P.
Pivotal bioVenture Partners Fund I G.P., L.P.
DiRocco Derek
Form 13F Holdings
Firm Period DFND Voting Shares
Y-Intercept (Hong Kong) Ltd [2026-06-30] SOLE 28,398 28,398
Gamma Investing LLC [2026-06-30] DFND 24 24
Prev | Page 9 | Next
Terms | Privacy | Providers | Guide
tony@aum13f.com